The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.

Medically reviewed by Mary Choy, PharmD Some people who take Ozempic (semaglutide)—a drug for diabetes management and weight ...

Last month, the scientists behind Ozempic – hailed as a ‘miracle drug’ for weight-loss – were honoured by the Breakthrough ...

(CNN) – The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten. A federal deadline to halt sales of the ...

Ozempic is an injectable semaglutide medication approved by the Food and Drug Administration (FDA) to help manage type 2 diabetes and assist in blood sugar management, alongside lifestyle changes.

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.